Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Wave Life Sciences (WVE) Current Deferred Tax Assets (2016)

Wave Life Sciences (WVE) has disclosed Current Deferred Tax Assets for 2 consecutive years, with $214000.0 as the latest value for Q4 2016.

  • For the quarter ending Q4 2016, Current Deferred Tax Assets rose 1088.89% year-over-year to $214000.0, compared with a TTM value of $214000.0 through Dec 2016, up 1088.89%, and an annual FY2016 reading of $214000.0, up 1088.89% over the prior year.
  • Current Deferred Tax Assets was $214000.0 for Q4 2016 at Wave Life Sciences, up from $23000.0 in the prior quarter.
  • Across five years, Current Deferred Tax Assets topped out at $214000.0 in Q4 2016 and bottomed at $18000.0 in Q4 2015.